DaVita
DVA
#1886
Rank
A$15.02 B
Marketcap
A$224.77
Share price
-1.49%
Change (1 day)
-6.65%
Change (1 year)
DaVita Inc. is an American company providing dialysis services for patients with chronic and acute kidney failure.

EPS for DaVita (DVA)

EPS in 2025 (TTM): A$15.45

According to DaVita's latest financial reports the company's current EPS (TTM) is A$14.73. In 2024 the company made an earnings per share (EPS) of A$16.05 an increase over its 2023 EPS that were of A$11.08.

EPS history for DaVita from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)A$15.45-3.79%
2024A$16.0544.94%
2023A$11.0827.26%
2022A$8.70-35.56%
2021A$13.5144.1%
2020A$9.3719.7%
2019A$7.83540.48%
2018A$1.22-76.07%
2017A$5.11-19.31%
2016A$6.33242.52%
2015A$1.85-62.87%
2014A$4.9813.43%
2013A$4.398.45%
2012A$4.05

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Universal Health Services
UHS
A$34.16 131.92%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
A$15.33 4.05%๐Ÿ‡บ๐Ÿ‡ธ USA
Tenet Healthcare
THC
A$21.40 45.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Pediatrix Medical Group
MD
A$2.76-81.24%๐Ÿ‡บ๐Ÿ‡ธ USA